3.0
Dec 7, 2017
Recommend
CEO approval
Business Outlook
Pros
The company is a leading biotech and exciting technology and products. Pays well and stock option may be a value.
Cons
Life balance is poor. Management is not doing a good job and put too much pressure on employees. Stock options become less valuable.